Intraventricular injection of neurotensin reduces the binding of dopamine D-2 receptors in the rat forebrain.
von Euler
G
G
Department of Histology and Neurobiology, Karolinska Institute, Stockholm, Sweden.
Meister
B
B
Hökfelt
T
T
Fuxe
K
K
D000818:Animals; D001058:Apomorphine / Q000031:analogs & derivatives / Q000378:metabolism; D001921:Brain / Q000378:metabolism*; D003342:Corpus Striatum / Q000378:metabolism; D007276:Injections, Intraventricular; D008297:Male; D009496:Neurotensin / Q000008:administration & dosage*; D009714:Nucleus Accumbens / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D011954:Receptors, Dopamine / Q000378:metabolism*
D011954:Receptors, Dopamine; D009496:Neurotensin; C009074:N-n-propylnorapomorphine; D001058:Apomorphine